Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

Reader response: Unintended consequences of Mayo paraneoplastic evaluations.

Pittock SJ, Mills JR, McKeon A.

Neurology. 2019 Sep 24;93(13):606. doi: 10.1212/WNL.0000000000008179. No abstract available.

PMID:
31551274
2.

Neurochondrin neurological autoimmunity.

Shelly S, Kryzer TJ, Komorowski L, Miske R, Anderson MD, Flanagan EP, Hinson SR, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2019 Sep 11;6(6). pii: e612. doi: 10.1212/NXI.0000000000000612. Print 2019 Nov.

3.

Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG.

Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Komorowski L, Scharf M, Hinson SR, Lennon VA, Pittock SJ, Klein CJ, McKeon A.

Neurology. 2019 Sep 3;93(10):e954-e963. doi: 10.1212/WNL.0000000000008061. Epub 2019 Aug 1. Erratum in: Neurology. 2019 Oct 1;93(14):647.

4.

Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity.

Zekeridou A, Kryzer T, Guo Y, Hassan A, Lennon V, Lucchinetti CF, Pittock S, McKeon A.

Neurology. 2019 Aug 20;93(8):e815-e822. doi: 10.1212/WNL.0000000000007971. Epub 2019 Jul 17.

5.

Kelch-like Protein 11 Antibodies in Seminoma-Associated Paraneoplastic Encephalitis.

Mandel-Brehm C, Dubey D, Kryzer TJ, O'Donovan BD, Tran B, Vazquez SE, Sample HA, Zorn KC, Khan LM, Bledsoe IO, McKeon A, Pleasure SJ, Lennon VA, DeRisi JL, Wilson MR, Pittock SJ.

N Engl J Med. 2019 Jul 4;381(1):47-54. doi: 10.1056/NEJMoa1816721.

PMID:
31269365
6.

Intrathecal administration of autologous mesenchymal stem cells in multiple system atrophy.

Singer W, Dietz AB, Zeller AD, Gehrking TL, Schmelzer JD, Schmeichel AM, Gehrking JA, Suarez MD, Sletten DM, Minota Pacheco KV, Coon EA, Sandroni P, Benarroch EE, Fealey RD, Matsumoto JY, Bower JH, Hassan A, McKeon A, Windebank AJ, Mandrekar JN, Low PA.

Neurology. 2019 Jul 2;93(1):e77-e87. doi: 10.1212/WNL.0000000000007720. Epub 2019 May 31.

PMID:
31152011
7.

GABAA receptor autoimmunity: A multicenter experience.

O'Connor K, Waters P, Komorowski L, Zekeridou A, Guo CY, Mgbachi VC, Probst C, Mindorf S, Teegen B, Gelfand JM, Geschwind MD, Lennon V, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 4;6(3):e552. doi: 10.1212/NXI.0000000000000552. eCollection 2019 May.

8.

HIV Controllers Exhibit Effective CD8+ T Cell Recognition of HIV-1-Infected Non-activated CD4+ T Cells.

Monel B, McKeon A, Lamothe-Molina P, Jani P, Boucau J, Pacheco Y, Jones RB, Le Gall S, Walker BD.

Cell Rep. 2019 Apr 2;27(1):142-153.e4. doi: 10.1016/j.celrep.2019.03.016.

9.

A multicenter comparison of MOG-IgG cell-based assays.

Waters PJ, Komorowski L, Woodhall M, Lederer S, Majed M, Fryer J, Mills J, Flanagan EP, Irani SR, Kunchok AC, McKeon A, Pittock SJ.

Neurology. 2019 Mar 12;92(11):e1250-e1255. doi: 10.1212/WNL.0000000000007096. Epub 2019 Feb 6.

10.

Antibody Prevalence in Epilepsy and Encephalopathy score: Increased specificity and applicability.

Dubey D, Pittock SJ, McKeon A.

Epilepsia. 2019 Feb;60(2):367-369. doi: 10.1111/epi.14649. No abstract available.

PMID:
30727035
11.

Autoimmune glial fibrillary acidic protein astrocytopathy.

Kunchok A, Zekeridou A, McKeon A.

Curr Opin Neurol. 2019 Jun;32(3):452-458. doi: 10.1097/WCO.0000000000000676.

12.

Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.

Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, Weinshenker BG, Shosha E, Lucchinetti CF, Fryer JP, Lopez-Chiriboga AS, Chen JC, Jitprapaikulsan J, McKeon A, Gadoth A, Keegan BM, Tillema JM, Naddaf E, Patterson MC, Messacar K, Tyler KL, Flanagan EP.

JAMA Neurol. 2019 Mar 1;76(3):301-309. doi: 10.1001/jamaneurol.2018.4053.

PMID:
30575890
13.

Paraneoplastic neuronal intermediate filament autoimmunity.

Basal E, Zalewski N, Kryzer TJ, Hinson SR, Guo Y, Dubey D, Benarroch EE, Lucchinetti CF, Pittock SJ, Lennon VA, McKeon A.

Neurology. 2018 Oct 30;91(18):e1677-e1689. doi: 10.1212/WNL.0000000000006435. Epub 2018 Oct 3.

14.

Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction.

Dubey D, Kothapalli N, McKeon A, Flanagan EP, Lennon VA, Klein CJ, Britton JW, So E, Boeve BF, Tillema JM, Sadjadi R, Pittock SJ.

J Neuroimmunol. 2018 Oct 15;323:62-72. doi: 10.1016/j.jneuroim.2018.07.009. Epub 2018 Jul 25.

PMID:
30196836
15.

Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine-rich glioma-inactivated protein 1.

Feyissa AM, Lamb C, Pittock SJ, Gadoth A, McKeon A, Klein CJ, Britton JW.

Epilepsia Open. 2018 Jun 25;3(3):348-356. doi: 10.1002/epi4.12226. eCollection 2018 Sep.

16.

Subacute encephalitis with recovery in IgLON5 autoimmunity.

Ramanan VK, Crum BA, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2018 Jul 20;5(5):e485. doi: 10.1212/NXI.0000000000000485. eCollection 2018 Sep. No abstract available.

17.

Ganglionic Antibody Level as a Predictor of Severity of Autonomic Failure.

Cutsforth-Gregory JK, McKeon A, Coon EA, Sletten DM, Suarez M, Sandroni P, Singer W, Benarroch EE, Fealey RD, Low PA.

Mayo Clin Proc. 2018 Oct;93(10):1440-1447. doi: 10.1016/j.mayocp.2018.05.033. Epub 2018 Aug 28.

18.

LGI1 and CASPR2 neurological autoimmunity in children.

López-Chiriboga AS, Klein C, Zekeridou A, McKeon A, Dubey D, Flanagan EP, Lennon VA, Tillema JM, Wirrell EC, Patterson MC, Gadoth A, Aaen JG, Brenton JN, Bui JD, Moen A, Otten C, Piquet A, Pittock SJ.

Ann Neurol. 2018 Sep;84(3):473-480. doi: 10.1002/ana.25310.

PMID:
30076629
19.

Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.

Chen JJ, Flanagan EP, Jitprapaikulsan J, López-Chiriboga ASS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ.

Am J Ophthalmol. 2018 Nov;195:8-15. doi: 10.1016/j.ajo.2018.07.020. Epub 2018 Jul 26.

20.

Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis.

Sechi E, Morris PP, McKeon A, Pittock SJ, Hinson SR, Weinshenker BG, Aksamit AJ, Krecke KN, Kaufmann TJ, Jolliffe EA, Zalewski NL, Zekeridou A, Wingerchuk DM, Jitprapaikulsan J, Flanagan EP.

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):488-490. doi: 10.1136/jnnp-2018-318004. Epub 2018 Jul 21. No abstract available.

PMID:
30032117
21.

Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.

López-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, Jitprapaikulsan J, Kothapalli N, Tillema JM, Chen J, Weinshenker B, Wingerchuk D, Sagen J, Gadoth A, Lennon VA, Keegan BM, Lucchinetti C, Pittock SJ.

JAMA Neurol. 2018 Nov 1;75(11):1355-1363. doi: 10.1001/jamaneurol.2018.1814.

22.

Autoimmune septin-5 cerebellar ataxia.

Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Fryer JP, Devine M, Flores A, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2018 Jul 9;5(5):e474. doi: 10.1212/NXI.0000000000000474. eCollection 2018 Sep. Erratum in: Neurol Neuroimmunol Neuroinflamm. 2018 Dec 12;6(1):e534.

23.

Sleep, Sleep Disorders, and Circadian Health following Mild Traumatic Brain Injury in Adults: Review and Research Agenda.

Wickwire EM, Schnyer DM, Germain A, Williams SG, Lettieri CJ, McKeon AB, Scharf SM, Stocker R, Albrecht J, Badjatia N, Markowitz AJ, Manley GT.

J Neurotrauma. 2018 Nov 15;35(22):2615-2631. doi: 10.1089/neu.2017.5243. Epub 2018 Aug 24.

PMID:
29877132
24.

Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1 year.

Dubey D, Hinson SR, Jolliffe EA, Zekeridou A, Flanagan EP, Pittock SJ, Basal E, Drubach DA, Lachance DH, Lennon VA, McKeon A.

J Neuroimmunol. 2018 Aug 15;321:157-163. doi: 10.1016/j.jneuroim.2018.04.016. Epub 2018 Apr 27.

PMID:
29793728
25.

Elevated LGI1-IgG CSF index predicts worse neurological outcome.

Gadoth A, Zekeridou A, Klein CJ, Thoreson CJ, Majed M, Dubey D, Flanagan EP, McKeon A, Jenkins SM, Lennon VA, Pittock SJ.

Ann Clin Transl Neurol. 2018 Apr 2;5(5):646-650. doi: 10.1002/acn3.561. eCollection 2018 May.

26.

Engineering modular intracellular protein sensor-actuator devices.

Siciliano V, DiAndreth B, Monel B, Beal J, Huh J, Clayton KL, Wroblewska L, McKeon A, Walker BD, Weiss R.

Nat Commun. 2018 May 14;9(1):1881. doi: 10.1038/s41467-018-03984-5.

27.

Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.

Jitprapaikulsan J, Chen JJ, Flanagan EP, Tobin WO, Fryer JP, Weinshenker BG, McKeon A, Lennon VA, Leavitt JA, Tillema JM, Lucchinetti C, Keegan BM, Kantarci O, Khanna C, Jenkins SM, Spears GM, Sagan J, Pittock SJ.

Ophthalmology. 2018 Oct;125(10):1628-1637. doi: 10.1016/j.ophtha.2018.03.041. Epub 2018 Apr 30.

PMID:
29716788
28.

Teaching Video NeuroImages: Acquired focal neuromyotonia in LGI-1 autoimmunity.

López Chiriboga AS, Matsumoto J, Sorenson E, Klein CJ, McKeon A.

Neurology. 2018 May 1;90(18):e1636-e1637. doi: 10.1212/WNL.0000000000005426. No abstract available.

PMID:
29712816
29.

Novel Glial Targets and Recurrent Longitudinally Extensive Transverse Myelitis.

Jitprapaikulsan J, Lopez Chiriboga AS, Flanagan EP, Fryer JP, McKeon A, Weinshenker BG, Pittock SJ.

JAMA Neurol. 2018 Jul 1;75(7):892-895. doi: 10.1001/jamaneurol.2018.0805. No abstract available.

30.

Glial fibrillary acid protein: Functions and involvement in disease.

McKeon A, Benarroch EE.

Neurology. 2018 May 15;90(20):925-930. doi: 10.1212/WNL.0000000000005534. Epub 2018 Apr 13. No abstract available.

PMID:
29653988
31.

GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.

Liimatainen S, Honnorat J, Pittock SJ, McKeon A, Manto M, Radtke JR; T1D Exchange Biobank, Hampe CS.

Orphanet J Rare Dis. 2018 Apr 10;13(1):55. doi: 10.1186/s13023-018-0787-5.

32.

Micro-Capillary Coatings Based on Spiropyran Polymeric Brushes for Metal Ion Binding, Detection, and Release in Continuous Flow.

Dunne A, Delaney C, McKeon A, Nesterenko P, Paull B, Benito-Lopez F, Diamond D, Florea L.

Sensors (Basel). 2018 Apr 4;18(4). pii: E1083. doi: 10.3390/s18041083.

33.

Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.

Chen JJ, Tobin WO, Majed M, Jitprapaikulsan J, Fryer JP, Leavitt JA, Flanagan EP, McKeon A, Pittock SJ.

JAMA Ophthalmol. 2018 Apr 1;136(4):419-422. doi: 10.1001/jamaophthalmol.2017.6757.

34.

Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders.

Hinson SR, Lopez-Chiriboga AS, Bower JH, Matsumoto JY, Hassan A, Basal E, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2018 Jan 23;5(2):e438. doi: 10.1212/NXI.0000000000000438. eCollection 2018 Mar.

35.

Clinical presentation of autoimmune and viral encephalitides.

Dubey D, Toledano M, McKeon A.

Curr Opin Crit Care. 2018 Apr;24(2):80-90. doi: 10.1097/MCC.0000000000000483. Review.

PMID:
29401173
36.

ITPR1 autoimmunity: Frequency, neurologic phenotype, and cancer association.

Alfugham N, Gadoth A, Lennon VA, Komorowski L, Scharf M, Hinson S, McKeon A, Pittock SJ.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 8;5(1):e418. doi: 10.1212/NXI.0000000000000418. eCollection 2018 Jan. No abstract available.

37.

Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis.

Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, Gadoth A, Smith CY, Bryant SC, Klein CJ, Aksamit AJ, Toledano M, Boeve BF, Tillema JM, Flanagan EP.

Ann Neurol. 2018 Jan;83(1):166-177. doi: 10.1002/ana.25131.

38.

Calcium channel autoimmunity: Cerebellar ataxia and lambert-eaton syndrome coexisting.

Zalewski N, Lennon VA, Pittock SJ, Mckeon A.

Muscle Nerve. 2017 Dec 22. doi: 10.1002/mus.26053. [Epub ahead of print]

PMID:
29272039
39.

Composite ganglioside autoantibodies and immune treatment response in MMN and MADSAM.

Martinez-Thompson JM, Snyder MR, Ettore M, McKeon A, Pittock SJ, Roforth MM, Mandrekar J, Mauermann ML, Taylor BV, Dyck PJB, Windebank AJ, Klein CJ.

Muscle Nerve. 2018 Jun;57(6):1000-1005. doi: 10.1002/mus.26051. Epub 2018 Jan 26.

PMID:
29272035
40.

Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases.

Dubey D, Lennon VA, Gadoth A, Pittock SJ, Flanagan EP, Schmeling JE, McKeon A, Klein CJ.

Neurology. 2018 Jan 9;90(2):e103-e110. doi: 10.1212/WNL.0000000000004803. Epub 2017 Dec 8.

PMID:
29222126
41.

Optic Disc Edema in Glial Fibrillary Acidic Protein Autoantibody-Positive Meningoencephalitis.

Chen JJ, Aksamit AJ, McKeon A, Pittock SJ, Weinshenker BG, Leavitt JA, Morris PP, Flanagan EP.

J Neuroophthalmol. 2018 Sep;38(3):276-281. doi: 10.1097/WNO.0000000000000593.

PMID:
29210929
42.

A path to understanding autoimmune GFAP astrocytopathy.

Zekeridou A, McKeon A, Flanagan EP.

Eur J Neurol. 2018 Mar;25(3):421-422. doi: 10.1111/ene.13527. Epub 2017 Dec 18. No abstract available.

PMID:
29193488
43.

Purkinje cell cytoplasmic antibody type I (anti-Yo): predictive of gastrointestinal adenocarcinomas in men.

Linnoila J, Guo Y, Gadoth A, Raghunathan A, Parks B, McKeon A, Lucchinetti CF, Lennon VA, Pittock SJ.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1116-1117. doi: 10.1136/jnnp-2017-316829. Epub 2017 Nov 15. No abstract available.

PMID:
29142142
44.

Breast cancer-related paraneoplastic neurologic disease.

Murphy BL, Zalewski NL, Degnim AC, McKeon A, Flanagan EP, Pittock SJ, Habermann EB.

Breast Cancer Res Treat. 2018 Feb;167(3):771-778. doi: 10.1007/s10549-017-4566-0. Epub 2017 Nov 7.

PMID:
29116466
45.

A novel tool for naturalistic assessment of behavioural dysregulation after traumatic brain injury: A pilot study.

McKeon A, Terhorst L, Skidmore E, Ding D, Cooper R, McCue M.

Brain Inj. 2017;31(13-14):1781-1790. doi: 10.1080/02699052.2017.1388444. Epub 2017 Oct 24.

PMID:
29064733
46.

Platinum(iv) oxaliplatin-peptide conjugates targeting memHsp70+ phenotype in colorectal cancer cells.

McKeon AM, Noonan J, Devocelle M, Murphy BM, Griffith DM.

Chem Commun (Camb). 2017 Oct 12;53(82):11318-11321. doi: 10.1039/c7cc04764a.

PMID:
28967013
47.

Immune-Mediated Autonomic Neuropathies following Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia.

Mangaonkar A, Khateeb HA, Duma N, St Louis EK, McKeon A, Patnaik M, Hogan W, Litzow M, Kourelis T.

Case Rep Hematol. 2017;2017:6803804. doi: 10.1155/2017/6803804. Epub 2017 Aug 27.

48.

Sleep in PTSD: Conceptual model and novel directions in brain-based research and interventions.

Germain A, McKeon AB, Campbell RL.

Curr Opin Psychol. 2017 Apr;14:84-89. doi: 10.1016/j.copsyc.2016.12.004. Epub 2016 Dec 26. Review.

PMID:
28813325
49.

IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients.

Honorat JA, Komorowski L, Josephs KA, Fechner K, St Louis EK, Hinson SR, Lederer S, Kumar N, Gadoth A, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2017 Jul 18;4(5):e385. doi: 10.1212/NXI.0000000000000385. eCollection 2017 Sep.

50.

Opsoclonus-Myoclonus Syndrome during Rituximab Treatment for Autoimmune Autonomic Ganglionopathy.

Dumitrascu OM, McKeon A, Zuniga L, Grill MF, Goodman BP.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 26;4(5):e376. doi: 10.1212/NXI.0000000000000376. eCollection 2017 Sep. No abstract available.

Supplemental Content

Loading ...
Support Center